beta-benzo

Natural health product licensed in Canada

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal composition not provided.

Poly(sorbate) 20, Eau purifiée, Isopropanol, Carbomère 940, Bêta-caryophyllène, Triéthanolamine, Phénoxyéthanol

Population	Age	Quantity per serving	Frequency
Adultes, adolescents et enfants	minimum: 2 years	Not specified	Not specified

For the temporary relief of pain associated with cold sores/fever blisters/oral herpes.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Précautions et mises en garde
If symptoms do not improve within seven days, irritation, pain or redness persists or worsens, or swelling, rash or fever develops, consult your dentist or other health care practitioner promptly.
Contre-indications
If the following symptoms appear: weakness, confusion, headache, difficulty breathing and/or pale, gray or blue coloured skin, stop use and consult a health care practitioner. These symptoms may be signs of methemoglobinemia, a rare disorder, which may appear up to 2 hours after use. If allergic to benzocaine, do not use this product.
Effets indésirables connus
Hypersensitivity/allergy is known to occur. In such a case, discontinue use.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.